ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 618939 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 618939; 2) Community: the network communities that were significantly associated with the response to NSC 618939; 3) Molecule: the relationships between components within communities and NSC 618939; 4) MDR: the compounds that were significantly associated with the NSC 618939.

NSC Compound Enrichment Correlation
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.0459335986102865 0.17786019
NSC 732844 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-fluorobenzene 0.0459335986102865 0.13073453
NSC 741412 4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one 0.0459335986102865 0.031675397
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.0459335986102865 0.1128268
NSC 748533 1-[2-(3-Chlorophenyl)-2-oxoethyl]-2-acetylbenzimidazole 0.0459335986102865 0.16881227
NSC 92504 Null 0.0459335986102865 0.0023991846
NSC 94600 Camptothecin 0.0459335986102865 0.91072383
NSC 249956 CHAPLIATRIN 0.0474314077111082 0.076730613
NSC 359466 Null 0.0474314077111082 0.26378571
NSC 172614 9H-Purin-2-amine, 9-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.048939380959983 0.3011676
Total:119  Current:111    [First] [Prev] [Next] [Last]